An event during a specific period involving an on-site inspection by the Japan Fair Trade Commission over suspected violations of the Antimonopoly Act in transactions involving blood coagulation testing equipment and reagents, followed by the approval and implementation of a commitment plan. Although this did not result in a finding of violation, it concerns the company’s response to the investigation and the impact on its performance and reputation.